Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005
NCT00544258 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8
Last updated 2015-02-12
Summary
The purpose of this study is to determine the extent of systemic absorption of PEP005 when applied topically for the treatment of actinic keratoses.
Conditions
- Actinic Keratoses
Interventions
- DRUG
-
PEP005
Sponsors & Collaborators
-
Peplin
lead INDUSTRY
Principal Investigators
-
Janelle Katsamas · Peplin
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2008-05-31
- Completion
- 2008-05-31
Countries
- Australia
Study Locations
More Related Trials
-
A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand
NCT00544297 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis
NCT00852137 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
NCT00700063 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)
NCT00917306 ·Status: COMPLETED ·Phase: PHASE3
-
PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology
NCT01387711 ·Status: COMPLETED ·Phase: PHASE1
-
A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study
NCT00952783 ·Status: COMPLETED
-
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
NCT00742391 ·Status: COMPLETED ·Phase: PHASE3
-
A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
NCT00989313 ·Status: COMPLETED
-
PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy
NCT01449513 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
NCT00942604 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
NCT00915551 ·Status: COMPLETED ·Phase: PHASE3
-
PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects
NCT01302925 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis
NCT01214564 ·Status: COMPLETED ·Phase: PHASE2
-
Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis
NCT00021294 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions
NCT02124239 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors
NCT02813902 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers
NCT00850681 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers
NCT00850811 ·Status: COMPLETED ·Phase: PHASE1
-
A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
NCT00953732 ·Status: COMPLETED
-
Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis
NCT00987246 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
NCT00916006 ·Status: COMPLETED ·Phase: PHASE3
-
T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
NCT00002811 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of SOR007 Ointment for Actinic Keratosis
NCT03083470 ·Status: COMPLETED ·Phase: PHASE2
-
Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
NCT00524485 ·Status: TERMINATED ·Phase: NA
-
Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm
NCT01803477 ·Status: COMPLETED ·Phase: PHASE1/PHASE2